Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Why SharkNinja Stock Was a Big Winner This Week: https://g.foolcdn.com/editorial/images/747770/person-gazing-at-a-laptop-located-on-a-desk-already-supporting-two-pc-monitors.jpg
Why SharkNinja Stock Was a Big Winner This Week

SharkNinja (NYSE: SN) was quite the beast on the stock market over the past five trading days. Following the initiation of coverage from a researcher who considers it to be an unabashed buy, the

Why DexCom Stock Dove by 5% Today: https://g.foolcdn.com/assets/images/fool/tmf-logo_400x400.png
Why DexCom Stock Dove by 5% Today

A notable price target cut from an analyst was followed by a dip in the price of DexCom (NASDAQ: DXCM) stock on Friday. Investors traded out of the specialty medical device maker, reducing its value

Why Auto Stocks Were So Jumpy on Friday: https://g.foolcdn.com/editorial/images/747857/car-kicking-up-dirt-as-it-accelerates.jpg
Why Auto Stocks Were So Jumpy on Friday

The auto industry strike that went into effect Friday -- the latest work stoppage in what many are calling the "hot labor summer" of 2023 -- resulted in a lot of action in auto stocks. Many

Apple Could Jump 20% According to This Wall Street Analyst. Time to Buy?: https://g.foolcdn.com/editorial/images/747411/woman-looking-at-phone.jpg
Apple Could Jump 20% According to This Wall Street Analyst. Time to Buy?

Apple's (NASDAQ: AAPL) latest iPhones are ready to start shipping.

As Apple watchers know well, the tech giant releases a new model of its trademark smartphone each September, ahead of the peak

Why Acelyrin Stock Plummeted 59% This Week: https://g.foolcdn.com/editorial/images/747714/a-graph-showing-large-selling-of-global-stock-markets-crashing-in-2020.jpg
Why Acelyrin Stock Plummeted 59% This Week

Shares of Acelyrin (NASDAQ: SLRN) fell 58.5% this week, according to data provided by S&P Global Market Intelligence, after the recently public biopharmaceuticals company announced discouraging

Why Shares of Local Broadcaster Sinclair Rocketed Higher This Week: https://g.foolcdn.com/assets/images/fool/tmf-logo_400x400.png
Why Shares of Local Broadcaster Sinclair Rocketed Higher This Week

Shares of Sinclair (NASDAQ: SBGI) rocketed as much as 35% higher this week before giving up some gains, according to data provided by S&P Global Market Intelligence. The owner of hundreds of local

Is Advance Auto Parts Stock a Buy?: https://g.foolcdn.com/editorial/images/747353/auto-car-store-oil-change.jpg
Is Advance Auto Parts Stock a Buy?

While technology companies, particularly those with exposure to artificial intelligence, have received all the attention lately, some investors might be looking at more under-the-radar names to find

Why Southern Company's Dividend Is Even More Impressive Than You Think: https://g.foolcdn.com/editorial/images/747469/21_05_25-a-sign-with-the-word-dividends-next-to-a-money-roll-_gettyimages-186201544.jpg
Why Southern Company's Dividend Is Even More Impressive Than You Think

When it comes to dividends, achieving Dividend King status is pretty much the pinnacle of success for a company. There are a handful of publicly traded utilities that have the 50+ years of annual

2 Unstoppable AI Growth Stocks to Buy Now and Hold Forever: https://g.foolcdn.com/editorial/images/747264/gettyimages-1513403586.jpg
2 Unstoppable AI Growth Stocks to Buy Now and Hold Forever

The incredible potential of artificial intelligence (AI) has helped power strong gains for tech stock this year. On the other hand, valuations for many AI stocks have recently pulled back, and some

Who Won the Disney-Charter Dispute? The Answer Might Surprise You: https://g.foolcdn.com/editorial/images/747281/watching-tv-streaming-relaxing-entertainment.jpg
Who Won the Disney-Charter Dispute? The Answer Might Surprise You

Disney (NYSE: DIS) shareholders seemed to get some good news on Monday, ending a standoff with Charter Communications (NASDAQ: CHTR) that had led Disney to pull its programming from Charter's

Why Nexstar Media Stock Rose 15.2% This Week: https://g.foolcdn.com/editorial/images/747844/couple-on-couch-watching-news-on-tv.jpg
Why Nexstar Media Stock Rose 15.2% This Week

As of Friday at 2:30 p.m. ET, Nexstar Media Group's (NASDAQ: NXST) stock price had gained 15.2% this week, according to S&P Global Market Intelligence. The stock had been up as much as 19.1% during

Why Chewy Fell to a 52-Week Low Today: https://g.foolcdn.com/editorial/images/747856/dog-getting-treat-from-owner.jpg
Why Chewy Fell to a 52-Week Low Today

Shares of pet food e-commerce leader Chewy (NYSE: CHWY) were plunging today, down 5.3% and reaching an ignominious 52-week low.

There wasn't too much in the way of company-specific news today

Why Iovance Biotherapeutics Stock Rocketed 13% Higher Today: https://g.foolcdn.com/editorial/images/747853/medical-professionals-conferring-in-a-hospial-corridor.jpg
Why Iovance Biotherapeutics Stock Rocketed 13% Higher Today

Iovance Biotherapeutics (NASDAQ: IOVA) is being shifted to the fast track in its current approval process for an investigational drug. On news that the Food and Drug Administration (FDA) is willing

2 Stocks to Invest in Virtual Reality (VR): https://g.foolcdn.com/editorial/images/747444/virtual-reality-headset-oculus.jpg
2 Stocks to Invest in Virtual Reality (VR)

All eyes have been on artificial intelligence (AI) this year, with recent advances in chips elevating what is possible with the technology. However, many industries require the same hardware used

Prediction: 2 Artificial Intelligence (AI) Growth Stocks That Will Join Apple and Microsoft in the $2 Trillion Club by 2033: https://g.foolcdn.com/editorial/images/747482/an-illuminated-ai-icon-attached-to-a-circuit-board.jpg
Prediction: 2 Artificial Intelligence (AI) Growth Stocks That Will Join Apple and Microsoft in the $2 Trillion Club by 2033

One of the biggest shifts seen in the stock market over the past 20 years is the increasing supremacy of technology stocks. Roughly two decades ago, General Electric and ExxonMobil were the pinnacle

1 Green Flag for Nvidia in 2023, and 1 Red Flag: https://g.foolcdn.com/editorial/images/747279/engineer-using-a-digital-tablet-while-working-in-a-server-room.jpg
1 Green Flag for Nvidia in 2023, and 1 Red Flag

If you had to choose a stock market winner this year, it'd be hard to overlook Nvidia (NASDAQ: NVDA). The company's shares have skyrocketed roughly 210% since Jan. 1 as the company became a key

Why Amazon Pulled Back Today: https://g.foolcdn.com/editorial/images/747830/happy-excited-opening-cardboard-box-parcel.jpg
Why Amazon Pulled Back Today

Shares of Amazon (NASDAQ: AMZN) were falling on Friday, down as much as 3.2% at one point on the day.

Amazon has had a pretty strong year, with a 72.3% gain year to date even after today's pullback

Why AMD, Nvidia, Intel, TSMC, and Other Semiconductor Stocks Were Down Friday: https://g.foolcdn.com/editorial/images/747843/jose-najarro-2023-09-15t150730391.png
Why AMD, Nvidia, Intel, TSMC, and Other Semiconductor Stocks Were Down Friday

In today's video, I discuss why numerous semiconductor stocks were down on Friday. Check out the short video to learn more, consider subscribing, and click the special offer link below.

*Stock

Why Nikola Stock Popped (Again) Today: https://g.foolcdn.com/editorial/images/747821/20220323_nikola_tre_hero_3117_2-3.jpg
Why Nikola Stock Popped (Again) Today

Shares of Nikola (NASDAQ: NKLA) jumped as much as 20% early Friday, then settled to trade up around 3% as of 3:10 p.m. ET after the electric vehicle company announced an expansion of its dealer

Why Meta Stock Retreated Today: https://g.foolcdn.com/editorial/images/747828/1-simple-red-arrow-declining-stock-chart-on-a-white-checked-background.jpg
Why Meta Stock Retreated Today

Shares of social networking star Meta Platforms (NASDAQ: META) tumbled 2.3% through 2:35 p.m. ET Friday afternoon on reports of troubles dogging its all-important advertising business, responsible

Why Shares of Uranium Energy and NexGen Energy Popped Over 16% This Week: https://g.foolcdn.com/editorial/images/747827/nuclear-power-plant-cooling-towers-alternative-renewable-energy-2.jpg
Why Shares of Uranium Energy and NexGen Energy Popped Over 16% This Week

It's been a bumper week for uranium stocks, with shares of Uranium Energy (NYSEMKT: UEC) and NexGen Energy (NYSE: NXE) clocking some of the biggest gains in the industry. While Uranium Energy stock

Here's Why ApeCoin, Arbitrum, and Internet Computer Plunged This Week: https://g.foolcdn.com/editorial/images/747748/look-down-below.jpg
Here's Why ApeCoin, Arbitrum, and Internet Computer Plunged This Week

Interestingly, the past week has been a relatively stable one in the world of cryptocurrencies. On an aggregate basis, the crypto sector has slightly gained ground over the past seven trading days

Why Intel, Broadcom, and Applied Materials Plunged Today: https://g.foolcdn.com/editorial/images/747824/chart-stress-investor-financial-future.jpg
Why Intel, Broadcom, and Applied Materials Plunged Today

Shares of chip stocks Intel (NASDAQ: INTC), Broadcom (NASDAQ: AVGO), and semi-cap equipment maker Applied Materials (NASDAQ: AMAT) were falling on Friday, down as much as 2.7%, 2.9%, and 4.7% at

SEC's Gensler May Face an Unbeatable Foe in Crypto: https://g.foolcdn.com/editorial/images/747825/featured-daily-upside-image.png
SEC's Gensler May Face an Unbeatable Foe in Crypto

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

Gary Gensler

Why Shares of Dyne Therapeutics Fell This Week: https://g.foolcdn.com/editorial/images/747820/physician-going-over-results-with-patient.jpg
Why Shares of Dyne Therapeutics Fell This Week

Shares of Dyne Therapeutics (NASDAQ: DYN) were down more than 15% for the week, as of 1 p.m. on Friday, according to data provided by S&P Global Market Intelligence. The clinical-stage biotech's